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To determine long-term survival and prognostic factors, 208 patients with 
primary tracheal tumors were evaluated in a retrospective multicenter 
study including 26 centers. Ninety-four patients had squamous cell carci- 
noma, four had adenocarcinoma, 65 had adenoid cystic carcinoma, and 45 
patients had miscellaneous tumors. The following resections were per- 
formed: tracheal resection with primary anastomosis, 165; carinal resec- 
tion, 24; and laryngotracheal resection, 19. Postoperative mortality rate was 
10.5% and correlated with the length of the resection, the need for a 
laryngeal release, the type of resection, and the histologic type of the cancer. 
Fifty-nine percent of patients with tracheal cancer and 43% of patients with 
adenoid cystic carcinomas had postoperative radiotherapy. The 5- and 
10-year survivals, respectively, were 73% and 57% for adenoid cystic 
carcinomas and 47% and 36% for tracheal cancers (p < 0.05). Among 
patients with tracheal cancers, survival was significantly longer for those 
with complete resections than for those with incomplete resections. On the 
other hand, the presence of positive lymph nodes did not seem to decrease 
survival. Postoperative radiotherapy increased survival only in the case of 
incompletely resected tracheal cancers. Long-term prognosis was worsened 
by the occurence of second primary malignancies in patients with tracheal 
cancers and by the occurence of late pulmonary metastases in patients with 
adenoid cystic carcinomas. (J TItORAC CARDIOVASC SURG 1996;111:808-14) 
p r imary tracheal tumors, which are rare and rarely 
resectable, represent a heterogeneous group of 
benign and mal ignant umors. Few large series have 
been reported.  1-5 Surgical resection is considered 
the treatment of choice for such tumors when they 
are l imited and resectable. Prognosis and indica- 
tions for adjuvant treatment,  however, remain un- 
clear. In light of these facts, we decided to make a 
retrospective mult icenter study to examine a large 
number of cases of resection to determine long-term 
survival, prognostic factors, and indication of adju- 
vant radiotherapy. 
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Patients and methods 
Patient characteristics. A questionnaire was sent to all 
members of the French Society of Thoracic and Cardio- 
vascular Surgery to collect data on all patients operated 
on during a 23-year period. Data was collected from 26 
responding surgical centres (see Appendix) on 208 pa- 
tients operated on between 1970 and 1993. Overall, only 
10 teams operated on 10 patients or more. 
Ninety-eight patients had a tracheal cancer (94 squa- 
mous cell cancers and four adenocarcinomas), 65 patients 
had an adenoid cystic carcinoma, and 45 patients had 
another tracheal tumor. The last group represented a 
multitude of tumor types and varying degrees of malig- 
nancy, including both epithelial and mesenchymal neo- 
plasms (Table I). 
There were 148 male and 60 female patients; ages 
averaged 50 years and ranged from 8 to 75 years. Tracheal 
cancers occurred predominantly in men (92.5%) with a 
mean age of 54 years; most were cigarette smokers. On 
the other hand, adenoid cystic carcinomas occurred in 
patients with a mean age of 48 years, with a male-female 
ratio near 1 (54% female). 
Clinical symptoms were generally related to the tra- 
cheal obstruction (dyspnea, 42%; and acute respiratory 
failure, 29%); in contrast, some patients had nonspecific 
tracheobronchial symptoms (cough, 30%; and hemoptysis, 
36%). The mean duration of symptoms was 4 months for 
tracheal cancers, 8 months for the group with assorted 
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Table I. Histology o f  resected tracheal tumors 
Tumor type n 
Epithelial tumor 
Malignant 
Low grade 
Benign 
Mesenchymal tumor 
Benign 
Malignant 
Squamous cell carcinoma 94 
Adenocarcinoma 4 
Adenoid cystic arcinoma 65 
Mucoepidermoid tumor 5 
Carcinoid 9 
Papilloma 2 
Adenoma 3 
Myoepithelial cell tumor 1 
Neurofibroma 2 
Lipoma 1 
Fibroma 2 
Abrikosoff tumor 3 
Chondroma 5 
Leiomyoma 5 
Schwannoma 1 
Plasmocytoma 2 
Miscellaneous 2 
Chondrosarcoma 1 
Melanoma 1 
benign and malignant tumors, and 12 months for adenoid 
cystic carcinomas. Tumors were located on the subglottic 
trachea in 19 patients, on the cervical or mid trachea in 
163 patients, and on the carinal area in 26 patients. 
Seventy-one patients underwent a first procedure of 
relief of tracheal obstruction to treat an acute respiratory 
failure or better define location and size of the tumor and 
to allow better respiratory preparation before surgical 
resection. The tumor was initially removed by the follow- 
ing methods: 62 patients underwent a laser treatment, five 
patients underwent bronchoscopic relief of airway ob- 
struction and two underwent cryotherapy. Two who were 
patients operated on at the beginning of the series under- 
went tracheotomy as a primary procedure. 
Surgical approach was made through a cervicotomy in
61 patients, cervicotomy with split sternotomy in 23 
patients, full median sternotomy in 75 patients, and right 
lateral thoracotomy in 41 patients. Eight patients had 
complex surgical approaches, uch as trap door incision. 
One hundred forty-six patients underwent circumferen- 
tial tracheal resection with primary reconstruction, 19 
patients underwent partial tracheal resection (wedge re- 
section), 24 underwent carinal resection, and 19 under- 
went laryngotracheal resection (seven associated laryngec- 
tomies and 12 partial cricoid resections according to the 
Pearson technique6). Intraoperative ventilation was per- 
formed through the operative field with canulation of the 
distal trachea in 116 patients, 54 patients had conventional 
ventilation with a small tracheal tube left in place during 
the resection, and 38 patients had high-frequency jet 
ventilation. 
Tracheal resection had to be extended to the thyroid in 
30 patients, to the esophagus in four patients (lateral 
removal of the esophagus wall), to one lung in four 
patients (extensive invasion of one main bronchus), to a 
recurrent laryngeal nerve in seven patients, and to the 
Table II. Specimen characteristics 
Adenoid 
Tracheal cystic 
cancers carcinomas Other 
(n = 98) (n - 65) (n = 45) 
Length of resection (ram) 38.5 + 14 38.5 _+ 14 29 -+ 13 
Positive resection margins 26 38 9 
(%) 
Positive lymph node 30 6 0 
Complete resection 70 59 81 
Incomplete resection 30 41 9 
vena cava in two patients. In addition to systematic 
anterior tracheal dissection and cervical flexion, 63 pa- 
tients underwent laryngeal release to lessen tension on the 
anastomosis. Fifty-one patients underwent a Dedo-Fish- 
man procedure, 7 nine patients underwent a Montgomery 
procedure, 8 and three patients underwent both. 
Table II shows specimen characteristics according to 
the three histologic types. Most patients with positive 
resection margins had only microscopic tumors present at 
the resection margins. 
Methods. This series was a retrospective multicenter 
study. Follow-up data were obtained for all but 10 patients 
until death or completion of the study. Mean foll0w-up 
was 4 years for patients operated on for tracheal cancers 
and 6 years for patients operated on for adenoid cystic 
carcinomas or other tumors. 
Survival was calculated by the actuarial method, 9 in- 
cluding postoperative deaths. Statistical comparisons be- 
tween survival curves were performed by the log rank test. 
The difference was considered significant when thep value 
was 0.05 or less. 
Results 
Postoperative course. One hundred twenty-four 
patients had uneventful postoperative courses; in 
contrast, 84 patients (41%) had postoperative com- 
plications (anastomotie leakage, 25; pneumopathy, 
13; and aspiration on deglutition, 29). Twenty-two 
patients (10.5%) died after operation. Four factors 
were significantly associated with postoperative 
complications: the length of resection (p < 0.001; 
the longer the tracheal resection, the higher the 
morbidity), the need for laryngeal release ~ < 
0.001), the type of surgical procedure (laryngotra- 
cheal or earinal resection vs standard tracheal resec- 
tion; p < 0.00l), and the histologic type (postoper- 
ative mortality rate was three times higher for 
squamous cell carcinomas than for other tumors 
(p < 0.05). The older age of the patient, positive 
margins at resection, and lymph node involvement 
did not significantly increase the postoperative com- 
plication rate. 
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Fig. 1. Actuarial survival curves according to histologic 
type (excluding 10 patients unavailable for follow-up). NS, 
Not significant. 
Table III shows the adjuvant treatment given after 
resection according to the two main histologic types. 
Postoperative treatment was not carried out per 
protocol in this retrospective study. Adjuvant reat- 
ment was administered more frequently to patients 
with incomplete resection or positive lymph nodes: 
31% in patients with complete resections versus 
71% in those with incomplete resections, and 35% 
in patients with negative nodes versus 80% in those 
with positive nodes. 
Long-term functional results were excellent in 137 
patients (76%). Eight (4%) patients had recurrent 
granulomas, nine patients had an asymptomatic 
stenosis, and 26 patients (14%) had a symptomatic 
stenosis. Late complications ecessitated laser treat- 
ment in 16 patients, tracheal stents in 12 patients, 
reresection i three patients, and permanent trache- 
otomy in four patients. Late complications (granu- 
lomas and stenosis) were significantly more frequent 
among patients who had postoperative locoregional 
complications (tracheal dehiscence and mediastini- 
tis) than among those who had an uneventful post- 
operative course. In fact, in absence of locoregional 
complication, 86% of the patients had excellent 
long-term functional results, and only 8% had a 
symptomatic stenosis. In cases of postoperative lo- 
coregional complication, only 56% of the patients 
had excellent long-term results, and 27% had a 
residual symptomatic stenosis (p < 0.001). 
Oneologie results. Oncologic results were mainly 
analyzed with respect o the two main histologic 
types (tracheal cancers and adenoid cystic carcino- 
mas). Among the patients operated on for tracheal 
cancers, 23 patients had locoregional recurrences 
and 10 had distant metastases, with a mean disease- 
free interval of 18 months. Furthermore, 17 patients 
Table III. Adjuvant reatment (patients urviving to 
resection) 
Tracheal Adenoid cystic 
cancers carcinomas 
(n = 83) (n = 60) 
None 34 34 
Radiotherapy 44 26 
Radiotherapy + chemotherapy 5 0 
had a second primary cancer (lung, 11; tongue, four; 
esophagus, one; and miscellaneous, one). In con- 
trast, among patients operated on for adenoid cystic 
carcinomas, 12 had distant metastases (pulmonary 
metastases, 12; associated with local recurrence, 
four; pleural metastases, one; and bone metastases, 
one), and nine patients had a locoregional recur- 
rence. Recurrences occurred later for adenoid cystic 
carcinomas (mean interval 51 months) than for 
tracheal cancers (mean interval 18 months; p < 
0.01). 
Fig. 1 shows the actuarial survival curves accord- 
ing to histologic type. As might be expected, prog- 
nosis for the heterogeneous group of benign and low 
malignant umors was good, with 5- and 10-year 
survivals of 77% and 71%, respectively. Survival was 
significantly longer for patients with adenoid cystic 
carcinomas than for patients with tracheal cancers: 
5- and 10-year survivals were respectively, 73% and 
57%, and 47% and 36% (log rank test, p < 0.05; Fig. 
1). Among patients with tracheal cancers, prognosis 
was significantly better for patients who had a 
complete resection than for those who had an 
incomplete resection; in fact, 5-year survivals were, 
respectively, 55% and 25% (p < 0.02). 
The presence of positive versus negative lymph 
nodes did not significantly decrease survival (Fig. 2), 
but 80% of patients with positive nodes underwent 
postoperative radiotherapy, versus 46% of patients 
with negative nodes (p < 0.001). Postoperative 
radiotherapy did not significantly improve survival 
for patients with completely resected tracheal can- 
cers (Fig. 3), however; postoperative radiotherapy 
improved survival significantly only in patients with 
incomplete resection (Fig. 4). Similarly, postopera- 
tive radiotherapy did not significantly improve sur- 
vival for patients with either positive or negative 
lymph nodes. 
Among patients with adenoid cystic carcinomas, 
survival seemed better for patients with complete 
resection than for those with incomplete resection, 
but the difference did not reach a significant level 
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Fig. 2. Survival according to lymph node involvement in 
tracheal cancers. NS, Not significant. 
(p < 0.20; Fig. 5). Similarly, postoperative radio- 
therapy or radiochemotherapy didnot improve sur- 
vival in the case of either complete or incomplete 
resection. 
Discussion 
Primary tracheal tumors are rare, and few large 
series have been reported. A prolonged period is 
needed to accumulate a sufficient number of cases, 
so we decided to make a retrospective multicenter 
study among the members of the French Society of 
Thoracic and Cardiovascular Surgery. As a result, 
this study represents one of the largest series re- 
ported in the literature, I-4 especially considering the 
number of squamous cell tracheal carcinomas. In 
contrast with the previously reported series, this 
series is characterized by the use of the actuarial 
method and the log rank test to better define 
long-term prognosis after resection and prognostic 
factors. Because of the retrospective and multi- 
center aspect of the series, however, surgical tech- 
niques, postoperative results, and indications for 
adjuvant treatment were heterogeneous. 
Oncologic results. This study confirms the good 
results of surgical resection of primary tracheal tu- 
mors. Long-term results in particular seem better for 
resectable squamous cell tracheal cancers than for 
resectable ung cancers) Surgical resection appears to 
be the treatment of choice for such tumors. 1'2 
According to Grillo and Mathisen, 1 irradiation 
alone does not appear to be an appropriate treat- 
ment for tracheal cancers. They compared the out- 
comes of patients operated on with those who were 
treated by irradiation alone and found that among 
the 17 patients with squamous cell tracheal cancers 
only one patient treated by irradiation alone was 
alive 1 year after the treatment; in contrast, 18 of the 
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Fig. 3. Influence of adjuvant radiotherapy on survival of 
patients with completely resected tracheal cancers (ex- 
cluding patients unavailable for follow-up and postopera- 
tive deaths). NS, Not significant. 
27 patients who underwent resection were still alive. 
Similar results were observed in adenoid cystic 
carcinomas. I Most authors recommend that irradi- 
ation alone should be reserved for patients with 
nonresectable disease. I' 10, ix 
In our series, the best prognostic factor for tra- 
cheal cancers was the completeness of resection; 
survival was significantly better among patients with 
complete resections than among those with incom- 
plete resections. Incomplete resection was generally 
related to positive resection margins; this result 
emphasizes the necessity of frozen-section analysis 
during operation to ensure performance of com- 
plete resection. Most patients with positive resection 
margins had only microscopic tumor residues found 
in the specimen, however; as a result, some patients 
with positive resection margins had long-term sur- 
vival when adjuvant radiotherapy was performed 
(Fig. 4). Although complete resection should be 
attempted, in some instances it is impossible to 
extend the resection without endangering the integ- 
rity of the anastomosis by creating excessive anasto- 
motic tension. As a result, the surgeon must some- 
times compromise total resection for safety. 
The rate of positive resection margins in this 
series was quite high; in fact, some surgical teams 
did not use systematic frozen-section analysis. In the 
series of Grillo and Mathisen, 1 frozen-section anal- 
ysis was systematically performed uring the opera- 
tion; nevertheless, the positive resection margin 
rates in that series were also quite high (23% for 
tracheal cancers and 29% for adenoid cystic carci- 
nomas). These results confirm the difficulty of per- 
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Fig. 4. Influence of adjuvant radiotherapy on survival of 
patients with incompletely resected tracheal cancers (ex- 
cluding patients unavailable for follow-up and postopera- 
tive deaths). 
forming complete resection of tracheal tumors with- 
out compromising the integrity of the procedure. 
Lymph node involvement did not seem to influ- 
ence long-term outcome in this series. In contrast to 
the series of Grillo and Mathisen, 1 patients with 
positive lymph nodes had a similar outcome to those 
without lymph node involvement (Fig. 2). We 
should point out, however, that 80% of the patients 
with positive lymph nodes received postoperative 
irradiation, compared with 35% of those with neg- 
ative lymph nodes. In our series postoperative ra- 
diotherapy did not significantly improve survival in 
patients with either negative or positive nodes. 
Nevertheless, postoperative radiotherapy signifi- 
cantly improved survival among patients with in- 
complete resection, generally related to positive 
resection margins. Because this was not a random- 
ized study and indications for postoperative radio- 
therapy varied from one team to another, it is not 
possible to draw definite conclusions from this se- 
ries. We therefore agree with Grillo and Mathisen, 1 
who emphasize the narrow margins often obtainable 
in tracheal resections and recommend postoperative 
radiotherapy for all patients, even when the margins 
and lymph nodes are histologically negative. 
The prognosis for adenoid cystic carcinomas is 
significantly better than that for squamous cell tra- 
cheal cancers (Fig. 1). In this field, survival was 
slightly better among patients with complete resec- 
tion than among those with incomplete resection, 
but the difference was not statistically significant 
(Fig. 5). 
If a complete resection is attempted, the safety of 
the resection should be the first aim of the surgeon, 
considering the good long-term results observed in 
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Fig. 5. Actuarial survival according to completeness of 
resection of adenoid cystic carcinomas. 
patients with microscopically positive resection mar- 
gins, especially with postoperative radiotherapy. 1' 7
In fact, adenoid cystic carcinomas are known for 
their proclivity to extend for long distances ubmu- 
cosally and perineurally, and the finding of malig- 
nant cells at a distance from the gross tumor is 
common, a The positive lymph node rate in adenoid 
cystic carcinomas was too low in our series to study 
the prognostic significance of this factor. 
The place of postoperative radiotherapy in the 
treatment of resectable adenoid cystic carcinomas i
extremely difficult to determine; postoperative ra- 
diotherapy could be recommended for patients with 
positive resection margins or nodes. Grillo and 
Mathisen 1 recommend such treatment for all pa- 
tients. As in other series, 1' 2 long-term survival was 
decreased by the occurrence of distant metastases. 
In contrast, in patients with tracheal cancers long- 
term survival was decreased by the occurrence of 
second primary malignancies generally related to 
tobacco habits (lung and tongue cancers). Surgical 
resection remains the treatment of choice for low- 
grade malignant tumors (such as carcinoid or mu- 
coepidermoid tumors), but benign tumors are now 
generally treated conservatively b  laser therapy or 
cryotherapy. 12 
Postoperative course. Morbidity and mortality 
associated with tracheal resections for tumors re- 
main high, especially in our series. This was due in 
part to the multicenter nature of this series; in fact, 
even though the surgical techniques have been well 
described, i, 2, 13, 14 for some surgical teams of this 
series the experience reported reflects a period of 
learning about surgical techniques and manage- 
ment. Some teams operated on only a few patients, 
and only seven teams collected ata from 10 patients 
or more. In the team who collected data from 41 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 111, Number 4 
Regnard, Fourquier, Levasseur 8 13 
patients, the mortality rate was 7.5%, which was not 
very different from those of Grillo and Mathisen I 
and Pearson and coworkers. 2 Furthermore, we dem- 
onstrated that postoperative mortality was three 
times higher for tracheal cancers than for adenoid 
cystic carcinomas or other tumors. As a result, the 
predominance of tracheal cancers in this series may 
explain the slightly higher mortality rate. The post- 
operative mortality rate was 6% among patients 
with adenoid cystic carcinoma or other tumors. The 
high mortality rate associated with tracheal cancers 
was probably related to the frequency of extensive 
tumors requiring extended resections and to the 
predominance of cigarette smokers in this group. 
Postoperative complications were significantly 
correlated with the difficulty of the surgical proce- 
dure (length of resection, laryngotracheal or carinal 
resections). On the other hand, no increase in 
postoperative complications was noted to be associ- 
ated with positive resection margins or lymph nodes. 
Furthermore, the postoperative course directly in- 
fluenced the long-term functional results, with a 
high rate of granulomas or stenosis in cases of 
postoperative locoregional complications. These 
stenoses were probably caused by partial necrosis of 
the suture related to excessive anastomotic tension 
or loss of the blood supply. As in the series of Grillo 
and Mathisen, 1 postoperative complications were 
more commonly associated with carinal resections 
than with standard tracheal resections. In these 
complex surgical procedures not only may surgical 
difficulties be present, some difficulties may occur 
during the intraoperative ventilation, followed by 
pulmonary complications. 
Surgical procedure. To lessen tension on the 
anastomosis, adjunctive procedures can be used in 
addition to systematic pretracheal dissection and 
cervical flexion. In this series, 63 patients underwent 
laryngeal release, which seems useful in patients 
undergoing extensive resection of the midtrachea. 
Some of these patients had aspiration on degluti- 
tion, but most cases resolved with time. For Grillo 
and Mathisen, 1 laryngeal release has not generally 
translated to relaxation after carinal resections, and 
in such procedures they recommends hilar dissec- 
tion with a complete incision of the pericardium 
around the hilum. 
Surgical resection is the treatment of choice of 
tracheal tumors. Postoperative courses remain dif- 
ficult in extended resections, particularly in cases of 
carinal or laryngotracheal resection. Such opera- 
tions should be performed by experienced teams. 
Primary relief of the tracheal obstruction by laser 
therapy should be considered to better prepare the 
patient for the resection, to decrease the inflamma- 
tion of the trachea, and to better assess the extent of 
the tumor and the possibility of a safe and complete 
resectionl Perfect surgical technique is mandatory to 
avoid anastomotic tension and to preserve the blood 
supply of the trachea. The place of adjuvant reat- 
ment must be determined by further randomized 
series. Long-term prognosis of tracheal cancers is 
worsened by the occurence of second primary ma- 
lignancies, and that of adenoid cystic carcinomas is 
worsened by the occurence of distant pulmonary 
metastases. 
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Discussion 
Dr. Claude Deschamps (Rochester, Minn.). I congratu- 
late Regnard and coworkers on an impressive collective 
series of tracheal resections. I have 0nly three technical 
questions. What is your standard approach and mode of 
ventilation for a carinal resection? Do you use vascular- 
ized tissue, such as omentum or muscle, to wrap the 
anastomosis; f so, in what circumstances? Finally, did you 
ever have to use a prosthesis for an extensive tracheal 
resection? 
Dr. Regnard. In response to your first question, I can 
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give you, first of all, the different approaches used in this 
series for carinal resection. Eight patients were operated 
on through a median sternotomy, 13 through a right 
posterolateral thoracotomy, and three through a trapdoor 
incision. For this collective group of operations, it there- 
fore seems that the best approach for carinal resection 
was the right posterolateral thoracotomy. Our opinion at 
Marie Lannelongue Hospital is quite different, however. 
We consider the best approach for carina! resection to be 
an anterior approach, generally performed through a full 
median sternotomy, if necessary combined with cervi- 
cotomy. In fact, with an anterior approach you can dissect 
the entire trachea, mobilize the entire trachea from the 
larynx to the main bronchus, and if necessary ou can 
perform a laryngeal release or a hilar release; the limits of 
this approach are probably some difficulties in the dissec- 
tion of the left main bronchus because of the presence of 
the aortic arch. Generally, however, we think that the first 
centimeters of the left main bronchus could be dissected 
and carinal resection could be performed this way. Fur- 
thermore, we consider that intraoperative ventilation is 
easier in patients in the supine position with an anterior 
approach, and we generally use jet ventilation for this type 
of resection. With this technique you can ventilate both 
lungs with two small catheters without difficulties and 
without damage. 
In response to your second question, we do not use 
systematically vascularized tissue to cover the anastomo- 
sis. I think only patients who have previously received high 
doses of radiation or high doses of steroids for a pro- 
longed time will benefit from vascularized tissue to cover 
the anastomosis. In these cases, I think that the best flap 
is probably an omental flap, which can easily be harvested 
with an additional small laparotomy. In two other in- 
stances, I think that it is better to cover the anastomosis: 
first, when the anastomosis is just against he innominate 
artery, in which case we generally use cervical muscles, 
sternocleidomastoidal muscles, to cover the anastomosis; 
and second, when the anastomosis is just against he right 
pulmonary artery after carinal resection, in which case we 
generally use fat tissue, mediastinal tissue, and pericar- 
dium to cover the anastomosis. 
In response to your third question, I do not know 
whether there is a place for prosthetics in tracheal resec- 
tion. We never use prostheses because published results 
have not been very encouraging. If a complete resection is
not possible because of longitudinal extent of the disease, 
we prefer to perform laser treatment combined with 
radiotherapy and chemotherapy rather than using a pros- 
thesis. 
Dr. F. Griflith Pearson (Toronto, Ontario, Canada). I
congratulate the French Thoracic Surgery Society for 
putting that information together. I am sure that it was 
hard work collecting data from so many surgeons and 
centers. You have produced some very useful and inter= 
esting information concerning a rare problem with which 
few centers or surgeons have an opportunity to obtain 
significant experience. 
Dr. Grillo of Boston has more personal experience with 
this tumor than anyone I know of, and he may choose to 
comment as well. I wish to emphasize some of your points 
regarding adenoid cystic carcinoma. Your data clearly 
show that this is a slowly progressive tumor and that the 
time from resection to local recurrence is frequently 
prolonged--almost 5 years in cases that did recur. I 
recently had a patient who died of a local recurrence that 
only became vident 27 years after the original incomplete 
resection. You also note that there are few metastases in 
lymph nodes in adenoid cystic cancers; most of the nodal 
metastases are probably due to direct overgrowth by the 
primary tumor itself. Some of these patients have pulmo- 
nary metastases, which may also remain asymptomatic for 
extremely long periods, and I would appreciate your 
comments in this regard. In my opinion, such asymptom- 
atic metastases are not necessarily a contraindication to 
resection of the primary tumor in selected cases. 
Finally, you make a plea for radiotherapy because of the 
narrow margins that are possible after resection of the 
mediastinal trachea. I support your recommendation. To
my knowledge, adenoid cystic cancer is highly radiore- 
sponsive in many cases. With radiotherapy alone, how- 
ever, no one has reportedly survived more than 10 years. 
From personal communication, I understand that Dr. 
Grillo has seen one patient who survived as long as 11 
years after irradiation only. In our own experience (I 
believe we have operated on about 36 patients with 
adenoid cystic cancer in a 30-year period), I have not seen 
a iocal recurrence in any patient in whom a complete 
resection was achieved at the initial operation. After an 
incomplete resection, however, the time to recurrence 
averaged about was 8 years. 
I greatly enjoyed the report, and I again congratulate 
you on what must have been very hard work digging out 
that information. 
Dr. Regnard. I totally agree with your comments. 
Appendix 
French Society Thoracic and Cardiovascular Surgery, 
authors and centers participating in the study: J. Bellamy, 
MD (Saint-Cloud); P. Bergeron, MD, P. Rudondy, MD 
(Marseilles), A. Bisson, MD (Suresnes); J. Borrelly, MD 
(Nancy); G. Chauvin, MD, B. Pena, MD (Avignon); 
L. Couraud, MD, J. Jougon, MD (Bordeaux); M. Dahan, 
MD, J. Berjaud, MD (Toulouse); B. Debesse, MD, 
M. Riquet, MD (Paris); C. Evrard, MD, B. Martel, MD 
(Caen); J. M. Faillon, MD (Lille); J. P. Gamondes, MD 
(Lyon); B. Guibert, MD (Lyons-Sud); L. K. Lacquet, MD 
(Nijmegen); G. Maggi, MD, A. Cavallo, MD (Turin); 
C. Marty-Anne, MD, H. Mary, MD (Montpellier); J. L. 
Michaud, MD, O. Baron, MD (Nantes); P. Mondine, MD, 
J. A. Barrat, MD (Brest); G. Morand, MD, G. Massard, 
MD (Strasbourg); J. F. Regnard, MD, P. Levasseur, MD 
(Le Plessis Robinson); H. Richelme, MD, J. Mouroux, 
MD (Nice); R. Sarrazin, MD, P. Y. Brichon, MD 
(Grenoble); P. Schneider, MD, I. Vogt-Moykopf, MD 
(Heidelberg); J. Sulzer, MD (Le Mans); B. Toumieux, 
MD, C. Dromer, MD (Tours); H. Viard, MD, A. Bernard, 
MD (Dijon); and A. Wurtz, MD, L. Gambiez, MD (Lille). 
